Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mRNA
Biotech
AACR: Cancer vaccines get a reintroduction
A session at the American Association for Cancer Research annual meeting asked a key question: Are cancer vaccines ready for prime time?
Annalee Armstrong
Apr 10, 2024 4:30am
AACR: BioNTech cancer vax spurs immune response 3 years in
Apr 7, 2024 2:00pm
CureVac, chasing Moderna mRNA flu shot, hits similar problems
Apr 4, 2024 9:30am
Peter Marks says FDA ready to review novel cancer vaccines
Apr 3, 2024 2:39pm
Blackstone bets $750M on Moderna's flu program
Mar 27, 2024 8:54am
Everest to continue mRNA ascent alone, ending Providence collab
Feb 20, 2024 8:19am